HOME >> BIOLOGY >> NEWS
Taxanes may enhance immunity in breast cancer patients

COLUMBUS, Ohio Breast cancer patients treated with taxanes as part of their chemotherapy regimen have stronger immune systems one year after completing therapy than do women undergoing similar treatments without taxanes a finding that turns conventional medical wisdom on its head.

Researchers in the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute studied 227 women enrolled in a multi-year study examining the relationship between stress and immunity in women with breast cancer. They divided the group into women who received taxanes as part of their treatment (55) and those who did not (172).

Researchers took blood from the patients and measured levels of key markers of the patients' immune status at two points in time, immediately after the women joined the study and one year following completion of treatment. Their analysis of the blood looked at the activity of the patient's T cells (white blood cells that can fight infections and cancer cells) and natural killer (NK) cells (another type of white blood cell that can kill cancer cells and cells infected with viruses).

They found that T cell growth was 37 percent higher and that the cancer killing activity of the NK cells was 39 percent higher in women receiving taxanes versus those who did not.

Scientists controlled for multiple variables that might contribute to the strength of the patients' immune function, including age, menopausal status, hormone receptor status, treatment, hormonal therapy at 12 months and cell counts, among others.

"This was totally unexpected," says Dr. William Carson, a surgeon and associate director of clinical research for the OSUCCC-James. "Most oncologists believe taxanes just like the rest of the chemotherapeutic agents we use suppress the immune system, not enhance it."

The study is published in the May 15 issue of Clinical Cancer Research.

Carson sa
'"/>

Contact: Michelle Gailiun
gailiun.1@osu.edu
614-293-3737
Ohio State University
6-May-2004


Page: 1 2

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Probing the surface of white blood cells to enhance immune system medicine
3. Protective gene may enhance vaccine responses
4. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
5. Technology could enhance accuracy of breast biopsy
6. Manipulating biotope space can enhance beneficial biodiversity effects
7. UC Riverside researchers develop low-carb corn with enhanced protein and oil
8. Athletics, genetic enhancement and ethics
9. Carnegie Mellon enhances Quantum Dot Corp. technology for long-term, live-animal imaging
10. Practice-based interventions enhance quality of care
11. Scientists discover potential approaches to enhance existing cancer therapies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Taxanes may enhance immunity breast cancer patients

(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, ... expected revenues in 2015 that relate to sales of FPC1155 for ... approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO of ... smartphone manufacturer in China and ... 155 for Z1 , ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that ... BV ("YouMedical"), a Dutch OTC company with operations in ... approximately EUR 16 million, with solid growth and leading ... is to build a leading international OTC company, and ... YouMedical gives us a stronger North European OTC platform, ...
(Date:8/30/2015)... , August 31, 2015 ... einer Frau   für chirurgische   Behandlung     ... 7-90   werden für eine   verheerende   ... Frauen behandeln und die Anzahl ausgebildeter Chirurgen in Kenia ... Astellas gab heute bekannt, dass  Action on Fistula  seit ...
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development ... for the quarter ended June 30, 2015, corporate ... and management report are available at www.sedar.com ... . "RepliCel expects to launch ...
(Date:8/27/2015)... 27, 2015  Neogen Corporation (NASDAQ: NEOG ) ... United Kingdom -based Lab M Holdings, ... and diagnostic systems. Lab M was ... provider of microbial testing and diagnostic products for the ... company currently sells into more than 70 countries worldwide, ...
Breaking Biology Technology:Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Neogen acquires U.K.-based Lab M Holdings 2
Cached News: